BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11167836)

  • 1. Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma.
    Pratt G; Fenton JA; Davies FE; Rawstron AC; Richards SJ; Collins JE; Owen RG; Jack AS; Smith GM; Morgan GJ
    Br J Haematol; 2001 Feb; 112(2):388-91. PubMed ID: 11167836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
    Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
    Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
    Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterisation of recombination events involving immunoglobulin heavy chain switch regions in multiple myeloma using long distance vectorette PCR (LDV-PCR).
    Proffitt J; Fenton J; Pratt G; Yates Z; Morgan G
    Leukemia; 1999 Jul; 13(7):1100-7. PubMed ID: 10400427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
    Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
    Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long distance vectorette PCR for detecting translocation of IgH gene in switch regions of patients with multiple myeloma].
    Guo C; Huo J; Jiang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):460-3. PubMed ID: 15972142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
    Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
    Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.
    Bergsagel PL; Nardini E; Brents L; Chesi M; Kuehl WM
    Curr Top Microbiol Immunol; 1997; 224():283-7. PubMed ID: 9308253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.
    Gabrea A; Bergsagel PL; Chesi M; Shou Y; Kuehl WM
    Mol Cell; 1999 Jan; 3(1):119-23. PubMed ID: 10024885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
    Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
    Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines.
    Kuipers J; Vaandrager JW; Weghuis DO; Pearson PL; Scheres J; Lokhorst HM; Clevers H; Bast BJ
    Cancer Genet Cytogenet; 1999 Mar; 109(2):99-107. PubMed ID: 10087940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
    Chesi M; Kuehl WM; Bergsagel PL
    Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
    Sawyer JR; Lukacs JL; Thomas EL; Swanson CM; Goosen LS; Sammartino G; Gilliland JC; Munshi NC; Tricot G; Shaughnessy JD; Barlogie B
    Br J Haematol; 2001 Jan; 112(1):167-74. PubMed ID: 11167798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells.
    Walker BA; Wardell CP; Johnson DC; Kaiser MF; Begum DB; Dahir NB; Ross FM; Davies FE; Gonzalez D; Morgan GJ
    Blood; 2013 Apr; 121(17):3413-9. PubMed ID: 23435460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
    Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
    Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias?
    Avet-Loiseau H; Minvielle S; Mellerin MP; Magrangeas F; Bataille R
    Hematol J; 2000; 1(5):292-4. PubMed ID: 11920205
    [No Abstract]   [Full Text] [Related]  

  • 18. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
    Tian E; Sawyer JR; Heuck CJ; Zhang Q; van Rhee F; Barlogie B; Epstein J
    Genes Chromosomes Cancer; 2014 Jul; 53(7):549-57. PubMed ID: 24638926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin and formation of chromosomal translocations in multiple myeloma].
    Nemec P; Kuglík P; Hájek R
    Klin Onkol; 2008; 21(2):53-8. PubMed ID: 19102212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival.
    Ho PJ; Brown RD; Pelka GJ; Basten A; Gibson J; Joshua DE
    Blood; 2001 Jan; 97(2):490-5. PubMed ID: 11154227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.